Skip to product information
1 of 1

MULTI SCIENCES

RUO Human IL-1beta ELISA Kit

RUO Human IL-1beta ELISA Kit

SKU:EK101B

Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

RUO Human IL-1beta ELISA Kit

Brand

MultiSciences

CatNum

70-EK101B

Product Name

Human IL-1beta ELISA Kit

Customs Name

Human IL-1beta ELISA Kit

Application

ELISA

Reactivity

Human

Assay Type

Sandwich ELISA

Suitable Sample Type

serum, plasma, cell culture supernates


Format 96-well strip plate

Storage

4℃ (unopened)standard stored at -20℃, others stored at 4℃ (opened)

Shipping Condition

4℃

Sample Volume

50 μl

Sensitivity

0.15 pg/ml

Standard Curve Range

3.91 - 250 pg/ml

Spike Recovery Range

94 % - 113 %

Mean Spike Recovery

1.05

CV of Intra plate

4.7 % - 6.1 %

CV of Inter plate

4.1 % - 6.6 %

Release Date

2015/4/1

Components

96-well polystyrene microplate coated with a monoclonal antibody against IL-1β

Human IL-1β Standard, lyophilized

IL-1β Detect Antibody

Standard Diluent

Streptavidin-HRP

Assay Buffer (10×)

Substrate (TMB)

Stop Solution

Washing Buffer (20×)

Plate Covers

Describtion

This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human IL-1β. The Human IL-1β ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Interleukin-1 (IL-1) is an extracellular peptide of 17 kDa that designates two proteins, IL-1α and IL-1β. IL-1β is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis.The interleukin-1 (IL-1) species represent an important family of biologically active mono nuclear cell-derived proteins which are involved in inflammatory reactions and in immune responses.

Increased production of IL-1β causes a number of different autoinflammatory syndromes, most notably the monogenic conditions referred to as CAPS, due to mutations in the inflammasome receptor NLRP3 which triggers processing of IL-1β.